CenterWatch and iiBIG's Optimizing Clinical Research Performance Forum Returns to Boston, Fall 2014

PORT WASHINGTON, N.Y., April 8, 2014 (GLOBE NEWSWIRE) -- CenterWatch and iiBIG are pleased to present the 2nd Annual Forum on Optimizing Clinical Research Performance, being held September 15-16, 2014, at the Sheraton Boston Hotel in Boston, Mass. Organized in a new day-and-a-half format with general sessions and strategically positioned break-out discussions, the conference will feature more than 30 thought-leaders at the forefront of driving change across the global clinical research landscape through novel collaboration and creative solutions. The conference is specifically designed to target an audience of senior-level clinical research professionals from healthcare providers, CROs, investigative sites and others in the clinical research space.

The conference will feature two keynote presentations: Kenneth I. Kaitin, Ph.D., Professor and Director, Tufts CSDD; Tufts University School of Medicine, will open the conference with "Deconstructing the Drug Development Process: Past Performance and Future Trends," and Ken Getz, Founder and Owner, CenterWatch; Director of Sponsored Research Programs, Tufts CSDD; Chairman, CISCRP, will present on "Insights in Patient Engagement: Key Issues and Trends" on the second day of the forum. The conference will conclude with a powerful closing plenary from Mark Weiner, M.D., a board-certified neurologist who self-diagnosed his brain cancer and will chronicle his journey in the presentation "When Doctor Becomes Patient."

The preliminary speaking faculty also includes representatives from Amgen; Aptiv Solutions; CDISC; ClinEdge; Clinical Research of South Florida; CORE/Benchmark Research; DrugDev; Edgemont Capital Partners; Endo Pharmaceuticals; Fairmount Partners; First Analysis; Parexel; PHT Corporation; PMG Research; Roche/Genentech; SunTrust Robinson Humphrey; Veeva Systems; and many more.

Early conference sponsors and exhibitors include: Aspire IRB, Benchmark Research, BRANY, Quorum IRB, CFS Clinical and DrugDev.

The agenda will focus on topics such as progressive solutions driving clinical research performance improvement, secrets of today's best performing drug developers, how private equity is affecting CRO/site consolidation, e-clinical technologies transforming drug development, and more.

For preliminary agenda and speaking faculty, please visit: http://www.iibig.com/CRAnnual

The Forum on Optimizing Clinical Research Performance is presented in partnership between CenterWatch, the global leader in providing timely and content-rich clinical research information and iiBIG, a leading presenter of professional B2B conferences for decision-makers in the healthcare, technology, and financial services sectors.

About CenterWatch

Since 1994, CenterWatch has been the recognized global leader in providing clinical trials information to a broad and influential spectrum of clinical research professionals ranging from top sponsors and CROs to research sites and niche providers, as well as an engaged population of patients interested in clinical research and volunteering. For more information, please visit: http://www.centerwatch.com.

About iiBIG

iiBIG (International Institute for Business Information & Growth) is an unbiased, independent company dedicated to organizing business-to-business conferences and seminars for senior-level business executives. For more information, please visit: http://www.iibig.com.

CONTACT: Don Buford
         Chief Executive Officer
         iiBIG (International Institute for
         Business Information & Growth)
         Phone: 212-300-2521
         E-mail: [email protected]
         http://www.iibig.com/CRAnnual

You May Also Be Interested In

• Tocvan Provides Corporate Update
• Avis Budget Group to Announce First Quarter 2024 Results on May 1st
• Ridgeline Minerals Announces Upsized Non-Brokered Private Placement to $2.2M